Back to Search Start Over

Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.

Authors :
Parmar, Gaganvir
Seftel, Matthew D.
Ganz, Kathy
Blake, John
Holovati, Jelena L.
Allan, David S.
Source :
Current Oncology. May2024, Vol. 31 Issue 5, p2542-2551. 10p.
Publication Year :
2024

Abstract

HLA-matched allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for many patients. Unrelated HLA-matched donors are the most frequently used donor for HCT. When more than one donor transplant option is available, transplant centers can select donors based on non-HLA factors. With improved ability to prevent and treat immune complications, such as graft-versus-host disease and infections, it may be possible to proceed more often using HLA-mismatched donors, allowing greater consideration of non-HLA factors, such as donor age, CMV serostatus, and ABO blood group matching, which have demonstrated important impacts on transplant outcomes. Additional factors to consider are donor availability rates and the usage of domestic donors to optimize outcomes. A review of non-HLA factors and considerations on the selection of optimal unrelated donors for HCT are provided within this updated current context. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11980052
Volume :
31
Issue :
5
Database :
Academic Search Index
Journal :
Current Oncology
Publication Type :
Academic Journal
Accession number :
177496569
Full Text :
https://doi.org/10.3390/curroncol31050190